[PDF] Top 20 Prediction of the response to chemotherapy in ovarian cancers
Has 10000 "Prediction of the response to chemotherapy in ovarian cancers" found on our website. Below are the top 20 most common "Prediction of the response to chemotherapy in ovarian cancers".
Prediction of the response to chemotherapy in ovarian cancers
... clinical response to che- motherapy in ovarian cancer [13, 14, 27, 30, 36, ...in ovarian cancers and clinical data have demonstrated no prognostic or pre- dictive value in estimations of MRP2 ... See full document
10
Prediction of clinical response to drugs in ovarian cancer using the chemotherapy resistance test (CTR-test)
... tual response rates of chemotherapies in ...the prediction of sensitivity (LDR) was correct, meaning that the patients did respond to the chosen chemotherapy and the CTR-Test predicted this outcome ... See full document
9
Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer
... of chemotherapy and consequently they will worsen the prognosis ...neoadjuvant chemotherapy has been successfully used in gynecologic oncology, in order to reduce the tumour mass and enable the optimal ... See full document
12
Screening of biomarkers for prediction of response to and prognosis after chemotherapy for breast cancers
... without chemotherapy, based on differential coexpression profile and differential coexpression enrichment methods, followed by DCsum function to summarize the final set of DCGs and ... See full document
8
Machine learning stratification for oncology patient survival
... the response compared with the biomarker ...of chemotherapy treatment on the predicted outcome and hence could be considered ...measure response to ...predicting response to a variety of ... See full document
209
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers
... PLD-based chemotherapy beyond second line in three different referral centers (Candiolo Cancer Institute FPO/IRCCS, Ordine Mauriziano Hospital and Sant’ Anna Hospital) between January 2010 and April ...of ... See full document
6
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer
... advanced ovarian cancer (AOC) include primary debulk- ing surgery (PDS) followed by platinum-based adju- vant chemotherapy [15] but, in some cases, the PDS is not feasible or is associated with unacceptable ... See full document
8
Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach
... in response to various treatments including photodynamic therapy, radiation therapy, chemotherapy, and anti- vascular therapy ...tumor response was suggested to improve the discrimination of ... See full document
18
Prediction of resistance to chemotherapy in ovarian cancer : a systematic review
... the response compared with the biomarker ...of chemotherapy treatment on the predicted outcome and hence could be considered predic- ...sure response to ...predicting response to a variety of ... See full document
33
ATP Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer
... The current study examined the CI and CI ranks of 10 che- motherapeutic agents that are used in the treatment of ovar- ian and peritoneal cancers. This study showed a trend to- ward an increased CI in recurrent ... See full document
9
Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic Cancers.
... clinical response to surgery and adjuvant chemotherapy will relapse and die of the ...of chemotherapy and bene fi ts of extended chemotherapy is ...in ovarian and other gynecologic ... See full document
15
Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive–compulsive disorder
... treatment response (responder, nonresponder, and refractory) and calculated the means of continuous variables or found the modes of nominal or ordinal features of these ... See full document
12
Response to targeted therapy or chemotherapy following immunotherapy in patients with gastrointestinal cancers - a case series
... partial response with decrease in size and arterial en- hancement of the main hepatic mass, in addition to stable abdominopelvic adenopathy and improvement in ascites ... See full document
6
Multiple primary tumours: challenges and approaches, a review
... primary cancers, diagnosis at young age and in several family ...and ovarian cancers, especially in younger patients, should prompt evaluation of an underlying hereditary breast and ovarian ... See full document
11
Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers
... by mechanistic DNA repair activity-informed design. Consequently, the approach has lacked a personalized medicine companion diagnostic strategy. Consistent with the requirement of the US Food and Drug Administration for ... See full document
11
The Chemopreventive Effect of CP-31398.
... spontaneous ovarian tumors, generally presenting after 2 years of ...human ovarian cancer because it is an excellent approximation of a premenopausal woman (Zhuge et ...developing ovarian ... See full document
87
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
... The response rate to second line treatment depends on the prevalence of plati- num resistance at that time ...different chemotherapy agents have shown some activity in patients with recurrent disease but ... See full document
10
Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer
... xenograft tumor growth and the intraperitoneal spread of the disease identifies a hitherto unknown function for JLP in providing a pro-tumorigenic physical conduit for JNK-signaling pathway. Studies in yeast have shown ... See full document
15
Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers
... Although several screening methods have been studied, including several tumour markers, none has been found yet to be particularly useful in reducing the incidence of advanced disease or mortality from ovarian ... See full document
9
Original Article Topoisomerase IIα and BRCA1 expression as predictive factors for anthracycline-based adjuvant chemotherapy response and prognosis in triple-negative breast cancers
... in response to anthracycline-based ...the response to anthracycline- based ...the response to individualized anthracycline treatment regimens for patients with ... See full document
10
Related subjects